Predictors of renal impairment and proteinuria after commencement of antiretroviral therapy in a Zimbabwean HIV cohort.

Abstract

Renal disease prevalence varies widely amongst reported cohorts of people living with HIV (PLWHIV) in sub-Saharan Africa. Renal function testing is not routine in those commencing antiretroviral therapy (ART) in the region, however. Further data on renal disease prevalence and the change associated with ART use are therefore needed. To explore changes in renal function and associated predictors after 1year of ART in an adult cohort of PLWHIV from Zimbabwe. A retrospective analysis of patients who attended the Newlands Clinic between January 2007 and September 2019. Eligible patients were aged ≥18years and had measures of serum creatinine at baseline and after 1year of ART. Predictors of renal function change were assessed by multiple linear regression. 1729 patients were eligible for inclusion. Median age was 36years (IQR 30-43) and 62.8% were female. After 1year of ART, the proportion of patients with an estimated glomerular filtration rate (eGFR) <60ml/min/1.732 did not significantly change (2.0% vs. 1.2%; p=0.094), but there was a decrease in the proportion of patients with proteinuria (11.0% vs. 5.6%; p<0.001). Hypertension (B=-6.43; 95% CI -8.97 to -3.89; p<0.001) and baseline proteinuria (B=-7.33; 95% CI -10.25 to -4.42; p<0.001) were negative predictors of change in eGFR from baseline, whereas diabetes status was not associated (p=0.476). Proteinuria was common, but its prevalence halved after 1year of ART. Screening for hypertension could be a simple way to identify patients at risk of renal function decline.